Boom in global Vaccine Investment to benefit Real Estate investors in the Middle East

Boom in global Vaccine Investment to benefit Real Estate investors in the Middle East

As part of its Impacts programme, Savills, the leading global real estate advisors, published some new research confirming the extent of estimated future global demand in laboratory and office space associated with life science . The research shows the extent to which venture capital (VC) funding into such companies boomed to US $2.3 billion by the end of August, comprising 1.2% of all global VC investment, up from an annual average of just 0.6% over the past five years. To further discuss the research, Savills hosted a webinar to highlight the most recent increase in demand from life sciences companies across the Middle East region. The panel titled 'Life Sciences - A Real Estate Bubble or Boom in the Middle East?' looked at the investors' interest in diversifying their portfolios to capture the expected increase in demand from life science companies. In order to understand the recent growth in this trend, Savills invited to the panel regional real estate and life science experts including Paula Walshe, Head of International Corporate Services at Savills, Marwan Abdulaziz, Managing Director at Dubai Science Park, Cenk Bildir, Senior Principle Project Manager at Medtronic and Graham MacGregor, Project Management Associate at Savills. The